Pernix Therapeutics Holdings (PTX) announced after the close Wednesday that it now expects to report first quarter net sales between $32 million and $35 million. Full year 2015 net sales are now expected to be between $220 million and $240 million. The consensus estimates are for revenues of $49.52 million and $237.47 million respectively. The stock is now down 0.97 on 27K shares.
Pernix Therapeutics Holdings traded to the downside during the first half of Wednesday's session and closed lower by 0.52 at $9.97. The stock closed testing the lower end of a 1-month trading range.
For comments and feedback contact: editorial@rttnews.com
Business News